Inflammation: Its role and interplay in the development of cancer, with special focus on gynecological malignancies

International Journal of Gynecological Cancer

Volumn 18, Issue 4, 2008, Pages 591-599

  Goswami, B ^a   Rajappa, M ^b   Sharma, M ^a   Sharma, A ^c  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cancer; Gynecological malignancies; Inflammation; Interleukins; NF B

Indexed keywords

CASPASE 3; CASPASE 9; CHEMOKINE RECEPTOR CXCR4; ENDOTHELIN 2; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; GELATINASE A; GELATINASE B; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PROSTAGLANDIN E2; PROTEIN C JUN; PROTEIN P50; PROTEIN P53; STAT1 PROTEIN; STAT3 PROTEIN; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR RELB; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULOTROPIN;

BREAST CANCER; CANCER GROWTH; CARCINOGENESIS; CELL TRANSFORMATION; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; ENDOMETRIUM CANCER; GENE MUTATION; GENETIC PREDISPOSITION; GYNECOLOGIC CANCER; HUMAN; INFLAMMATION; INFLAMMATORY CELL; MALIGNANT TRANSFORMATION; MICROENVIRONMENT; OVARY CANCER; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; UTERINE CERVIX CANCER;

CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MODELS, BIOLOGICAL; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 47649093316     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01089.x     Document Type: Review

References (61)

1. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002 420 : 860 67.
2. Rous P, Kidd J. Conditional neoplasms and subthreshold neoplastic states: a study of the tar tumors of rabbits. J Exp Med 1941 73 : 365 89.
3. Balkuru F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001 357 : 539 45.
4. Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Mol Cancer Res 2006 4 : 1 13.
5. Philip M, Rowley DA, Schreiber H. Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol 2004 14 : 433 9.
6. Nathan C. Points of control in inflammation. Nature 2002 420 : 846 52.
7. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000 100 : 57 70.
8. Okada F. Inflammation and free radicals in tumour development and progression. Redox rep 2002 7 : 357 68.
9. Parkin DM, Pisani P, Munoz N, Ferlay J. In : Newton R, Beral V, Weiss RA, eds. Infections and human cancer. Cold Spring Harbor, NY : Cold Spring Harbor Laboratory press, 1999.
10. Negus RPK, Stamp GWQ, Hadley J, Balkwill FR. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am J Pathol 1997 150 : 1723 34.
11. Lewis CE, Leek R, Harris A, McGee JOD. Cytokine regulation of angiogenesis in breast cancer: the role of tumour associated macrophages. J Leukol Biol 1995 57 : 747 51.
12. Dranoff G. Tumour immunology: immune recognition and tumour protection. Curr Opin Immunol 2002 14 : 161 64.
13. Butel S. Viral oncogenesis:revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 2000 21 : 405 26.
14. Martin-Green M, Boundreau N, Bissel MJ. Inflammation is responsible for the development of wound - induced tumour in chickens infected with Rous sarcoma virus. Cancer Res 1994 54 : 4334 41.
15. Talmor M. Generation of large numbers of immature and mature dendritic cells from rat bone marrow cultures. Eur J Immunol 1998 28 : 811 7.
16. Bouck N, Stellmach V, Hsu SC. How tumours become angiogenic. Adv Cancer Res 1996 69 : 135 74.
17. Lin EY, Pollard JW. Role of infiltrated leucocytes in tumor growth and spread. Br J Cancer 2004 90 : 2053 8.
18. Cordon-Cavdo C, Prives C. Commentary: at the crossroads of inflammation and tumorigenesis. J Exp Med 1999 190 : 1367 70.
19. O'Sullivan C, Lewis CE. Tumour associated leukocytes: friends or foes in breast carcinoma. J Pathol 1994 172 : 229 35.
20. Pollard JW. Tumour - educated macrophages promote tumor progression and metastasis. Nat Rev Cancer 2004 4 : 71 8.
21. Haqqani AS, Sandhu JK, Birnbiom HC. Expression of interleukin-8 promotes neutrophil infiltration and genetic instability in mutated tumours. Neoplasia 2000 2 : 561 8.
22. Smyth MJ, Cretney E, Kershaw MH, Hayakawa Y. Cytokines in cancer immunity and immunotherapy. Immunol Rev 2004 202 : 275 93.
23. Chung YC, Chang YF. Serum interleukin-6 levels reflect the disease status of colorectal cancer. Surg Oncol 2003 83 : 222 6.
24. Naylor MS, Stamp GWH, Foukes WD, Eccles D, Balkwill FR. Tumor necrosis factor and its receptor in human ovarian cancer. J Clin Invest 1993 91 : 2196 206.
25. Leek RD, Landers R, Fox SB, Ng F, Hartis AL, Lewis CE. Association of tumour necrosis factor and its receptor with thymidine phosphorylase expression in invasive breast carcinoma. Br J Cancer 1998 77 : 2246 51.
26. Luboshitz G, Shina S, Kaplan O. Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast cancer. Cancer Res 1999 59 : 4681 87.
27. Venkatkrishnan G, Salgia E, Groopman JE. Chemokine receptors CXCR-1/2 activate mitogen activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells. J Biol Chem 2000 275 : 6868 75.
28. Richmond A, Thomas H. Purification of melanoma growth stimulatory activity. J Cell Physiol 1986 129 : 375 84.
29. Muller A. Involvement of chemokine receptor in breast cancer metastasis. Nature 2001 410 : 50 6.
30. Maeda H, Akaike T. Nitric oxide and oxygen radicals in infection. Inflammation and cancer. Biochemistry 1998 63 : 854 65.
31. Goodman JE, Hofseth LS, Hussain SP, Harris CC. Nitric oxide and P53 in cancer prone chronic inflammation and oxyradical overload disease. Environ Mol Mutagen 2004 44 : 3 9.
32. Rao CV. Nitric oxide signalling in colon cancer chemoprevention. Mutat Res 2004 555 : 107 19.
33. Wiiliam CS, Mann M, Dubois RN. The role of cycloxygenases in inflammation, Cancer and development. Oncogene 1999 18 : 7906 16.
34. Baron JA, Sandler RS. Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu Rev Med 2000 51 : 511 23.
35. Garcia-Rodriguez L, Huerta-Alvarez C. Reduced risk of colorectal cancer among long tern users of aspirin and non-aspirin non-steroidal anti-inflammatory drugs. Epidemiol 2001 12 : 83 93.
36. Mamytbekova A, Rezabek K, Karcerovska H, Grimova J, Svobodava J. Antimetastatic effect of flurbiprofen and other platelets aggregation inhibitors. Neoplasma 1986 33 : 417 21.
37. Elder DJ, Hatton DF, Hague A, Parakeva C. Induction of apoptotic cell death in human colorectal carcinoma cells lines by a Cycloxygenase-2 (Cox-2) selective non-steroidal anti-inflammatory drug: independence from Cox-2 protein expression. Clin Cancer Res 1997 3 : 1679 83.
38. Nishikori M. Classical and alternative NF-κB activation pathways and their roles in lymphoid malignancies. J Clin Exp Hematopathol 2005 45 : 15 24.
39. Lin A, Karim M. NF-κB in cancer: a marked target. Semin Cancer Biol 2003 13 : 107 14.
40. May MJ, Ghosh S. Rel/NF-κB and I-κB proteins: an overview. Semin Cancer Biol 1997 8 : 63 73.
41. Karim M, Ben-Neriah Y. Phosphorylation meets ubiquitination: control of NF-κB activity. Annu Rev Immunol 2000 18 : 621 63.
42. Li Q, Verma IM. NF-κB regulation in the immune system. Nat Rev Immunol 2002 2 : 725 34.
43. Dobrovolskaia MA, Serguei V. Inflammation and cancer: when NF-κB amalgamates the perilous partnership. Curr Cancer Drug Targets 2005 5 : 325 44.
44. Karim M, Cao Y, Greten FR, Li ZW. NF-κB in cancer from innocent bystander to major culprit. Nat Rev Cancer 2002 2 : 301 10.
45. Pikarsky E, Porat RM, Stein I. NF-κB functions as a tumor promoter: in inflammation and cancer. Nature 2004 431 : 431 6.
46. Yoshimura A. Signal transduction of inflammatory cytokines and tumor development. Cancer Sci 2006 97 : 439 47.
47. Modugno F, Ness RB, Chen C, Weiss NS. Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev 2005 14 : 2840 7.
48. Ness RB, Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 1999 91 : 1459 67.
49. Purohit A, Newman SP, Reed MJ. The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer. Breast Cancer Res 2002 4 : 65 9.
50. Reed MJ, Purohit A. Breast cancer and the role of cytokines in regulating estrogen synthesis: an emerging hypothesis. Endo Rev 1997 18 : 701 15.
51. Smith JS, Herrero R, Bosetti C et al. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 2002 94 : 1604 13.
52. Castle PE, Hillier SL, Rabe LK et al. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev 2001 10 : 1021 7.
53. Yang YC, Chang CL, Huang YW, Wang DY. Possible cofactor in cervical carcinogenesis: proliferation index of the transformation zone in cervicitis. Chang Gung Med J 2001 24 : 615 20.
54. Schwebke JR, Zajackowski ME. Effect of concurrent lower genital tract infections on cervical cancer screening. Genitourin Med 1997 73 : 383 6.
55. Kiviat NB, Paavonen JA, Wolner-Hanssen P et al. Histopathology of endocervical infection caused by Chlamydia trachomatis, herpes simplex virus, Trichomonas vaginalis, and Neisseria gonorrhoeae. Hum Pathol 1990 21 : 831 7.
56. Carlson JA, Ambros R, Malfetano J et al. Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia. Hum Pathol 1998 29 : 932 48.
57. Berhane T, Halliday GM, Cooke B, Barnetson RS. Inflammation is associated with progression of actinic keratoses to squamous cell carcinomas in humans. Br J Dermatol 2002 146 : 810 5.
58. Jaiswal M, LaRusso NF, Gores GJ. Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am J Physiol Gastrointest Liver Physiol 2001 281 : G626 34.
59. Sharma A, Rajappa M, Saxena A et al. Antioxidant status in advanced cervical cancer patients undergoing neoadjuvant chemoradiation. Br J Biomed Sci 2007 64 : 23 7.
60. Sharma A, Rajappa M, Saxena A et al. Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix. Int J Gynecol Cancer 2007 17 : 879 85.
61. Sharma A, Rajappa M, Saxena A et al. Telomerase activity as tumour marker in early detection of cancer in Indian women with cervical intraepithelial neoplasia and cervical cancer. Mol Diagn Ther 2007 11 : 193 201.